Global Antibody Discovery Services Market Outlook, In‑Depth Analysis & Forecast to 2031

1 Study Coverage
1.1 Introduction to Antibody Discovery Services: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global Antibody Discovery Services Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 Discovery of CAR-T Antibody Drugs
1.2.3 Discovery of Monoclonal Antibody Drugs
1.2.4 Discovery of ADC Antibody Drugs
1.2.5 Others
1.3 Market Segmentation by Application
1.3.1 Global Antibody Discovery Services Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Biotechnology
1.3.3 Medical
1.3.4 University
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Antibody Discovery Services Revenue Estimates and Forecasts 2020-2031
2.2 Global Antibody Discovery Services Revenue by Region
2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031
2.2.2 Historical and Forecasted Revenue by Region (2020-2031)
2.2.3 Global Revenue Market Share by Region (2020-2031)
2.2.4 Emerging Market Focus: Growth Drivers & Investment Trends
3 Competition by Players
3.1 Global Antibody Discovery Services Player Revenue Rankings and Profitability
3.1.1 Global Revenue (Value) by Players (2020-2025)
3.1.2 Global Key Player Revenue Ranking (2023 vs. 2024)
3.1.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
3.1.4 Gross Margin by Top Player (2020 VS 2024)
3.2 Global Antibody Discovery Services Companies Headquarters and Service Footprint
3.3 Main Product Type Market Size by Players
3.3.1 Discovery of CAR-T Antibody Drugs Market Size by Players
3.3.2 Discovery of Monoclonal Antibody Drugs Market Size by Players
3.3.3 Discovery of ADC Antibody Drugs Market Size by Players
3.3.4 Others Market Size by Players
3.4 Global Antibody Discovery Services Market Concentration and Dynamics
3.4.1 Global Market Concentration (CR5 and HHI)
3.4.2 Entrant/Exit Impact Analysis
3.4.3 Strategic Moves: M&A, Expansion, R&D Investment
4 Global Product Segmentation Analysis
4.1 Global Antibody Discovery Services Revenue Trends by Type
4.1.1 Global Historical and Forecasted Revenue by Type (2020-2031)
4.1.2 Global Revenue Market Share by Type (2020-2031)
4.2 Key Product Attributes and Differentiation
4.3 Subtype Dynamics: Growth Leaders, Profitability and Risk
4.3.1 High-Growth Niches and Adoption Drivers
4.3.2 Profitability Hotspots and Cost Drivers
4.3.3 Substitution Threats
5 Global Downstream Application Analysis
5.1 Global Antibody Discovery Services Revenue by Application
5.1.1 Global Historical and Forecasted Revenue by Application (2020-2031)
5.1.2 Revenue Market Share by Application (2020-2031)
5.1.3 High-Growth Application Identification
5.1.4 Emerging Application Case Studies
5.2 Downstream Customer Analysis
5.2.1 Top Customers by Region
5.2.2 Top Customers by Application
6 North America
6.1 North America Market Size (2020-2031)
6.2 North America Key Players Revenue in 2024
6.3 North America Antibody Discovery Services Market Size by Type (2020-2031)
6.4 North America Antibody Discovery Services Market Size by Application (2020-2031)
6.5 North America Growth Accelerators and Market Barriers
6.6 North America Antibody Discovery Services Market Size by Country
6.6.1 North America Revenue Trends by Country
6.6.2 US
6.6.3 Canada
6.6.4 Mexico
7 Europe
7.1 Europe Market Size (2020-2031)
7.2 Europe Key Players Revenue in 2024
7.3 Europe Antibody Discovery Services Market Size by Type (2020-2031)
7.4 Europe Antibody Discovery Services Market Size by Application (2020-2031)
7.5 Europe Growth Accelerators and Market Barriers
7.6 Europe Antibody Discovery Services Market Size by Country
7.6.1 Europe Revenue Trends by Country
7.6.2 Germany
7.6.3 France
7.6.4 U.K.
7.6.5 Italy
7.6.6 Russia
8 Asia-Pacific
8.1 Asia-Pacific Market Size (2020-2031)
8.2 Asia-Pacific Key Players Revenue in 2024
8.3 Asia-Pacific Antibody Discovery Services Market Size by Type (2020-2031)
8.4 Asia-Pacific Antibody Discovery Services Market Size by Application (2020-2031)
8.5 Asia-Pacific Growth Accelerators and Market Barriers
8.6 Asia-Pacific Antibody Discovery Services Market Size by Region
8.6.1 Asia-Pacific Revenue Trends by Region
8.7 China
8.8 Japan
8.9 South Korea
8.10 Australia
8.11 India
8.12 Southeast Asia
8.12.1 Indonesia
8.12.2 Vietnam
8.12.3 Malaysia
8.12.4 Philippines
8.12.5 Singapore
9 Central and South America
9.1 Central and South America Market Size (2020-2031)
9.2 Central and South America Key Players Revenue in 2024
9.3 Central and South America Antibody Discovery Services Market Size by Type (2020-2031)
9.4 Central and South America Antibody Discovery Services Market Size by Application (2020-2031)
9.5 Central and South America Investment Opportunities and Key Challenges
9.6 Central and South America Antibody Discovery Services Market Size by Country
9.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)
9.6.2 Brazil
9.6.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Market Size (2020-2031)
10.2 Middle East and Africa Key Players Revenue in 2024
10.3 Middle East and Africa Antibody Discovery Services Market Size by Type (2020-2031)
10.4 Middle East and Africa Antibody Discovery Services Market Size by Application (2020-2031)
10.5 Middle East and Africa Investment Opportunities and Key Challenges
10.6 Middle East and Africa Antibody Discovery Services Market Size by Country
10.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)
10.6.2 GCC Countries
10.6.3 Israel
10.6.4 Egypt
10.6.5 South Africa
11 Corporate Profile
11.1 Biocytogen
11.1.1 Biocytogen Corporation Information
11.1.2 Biocytogen Business Overview
11.1.3 Biocytogen Antibody Discovery Services Product Features and Attributes
11.1.4 Biocytogen Antibody Discovery Services Revenue and Gross Margin (2020-2025)
11.1.5 Biocytogen Antibody Discovery Services Revenue by Product in 2024
11.1.6 Biocytogen Antibody Discovery Services Revenue by Application in 2024
11.1.7 Biocytogen Antibody Discovery Services Revenue by Geographic Area in 2024
11.1.8 Biocytogen Antibody Discovery Services SWOT Analysis
11.1.9 Biocytogen Recent Developments
11.2 Charles River Laboratories
11.2.1 Charles River Laboratories Corporation Information
11.2.2 Charles River Laboratories Business Overview
11.2.3 Charles River Laboratories Antibody Discovery Services Product Features and Attributes
11.2.4 Charles River Laboratories Antibody Discovery Services Revenue and Gross Margin (2020-2025)
11.2.5 Charles River Laboratories Antibody Discovery Services Revenue by Product in 2024
11.2.6 Charles River Laboratories Antibody Discovery Services Revenue by Application in 2024
11.2.7 Charles River Laboratories Antibody Discovery Services Revenue by Geographic Area in 2024
11.2.8 Charles River Laboratories Antibody Discovery Services SWOT Analysis
11.2.9 Charles River Laboratories Recent Developments
11.3 Abcam
11.3.1 Abcam Corporation Information
11.3.2 Abcam Business Overview
11.3.3 Abcam Antibody Discovery Services Product Features and Attributes
11.3.4 Abcam Antibody Discovery Services Revenue and Gross Margin (2020-2025)
11.3.5 Abcam Antibody Discovery Services Revenue by Product in 2024
11.3.6 Abcam Antibody Discovery Services Revenue by Application in 2024
11.3.7 Abcam Antibody Discovery Services Revenue by Geographic Area in 2024
11.3.8 Abcam Antibody Discovery Services SWOT Analysis
11.3.9 Abcam Recent Developments
11.4 Alloy Therapeutics
11.4.1 Alloy Therapeutics Corporation Information
11.4.2 Alloy Therapeutics Business Overview
11.4.3 Alloy Therapeutics Antibody Discovery Services Product Features and Attributes
11.4.4 Alloy Therapeutics Antibody Discovery Services Revenue and Gross Margin (2020-2025)
11.4.5 Alloy Therapeutics Antibody Discovery Services Revenue by Product in 2024
11.4.6 Alloy Therapeutics Antibody Discovery Services Revenue by Application in 2024
11.4.7 Alloy Therapeutics Antibody Discovery Services Revenue by Geographic Area in 2024
11.4.8 Alloy Therapeutics Antibody Discovery Services SWOT Analysis
11.4.9 Alloy Therapeutics Recent Developments
11.5 Creative Biolabs
11.5.1 Creative Biolabs Corporation Information
11.5.2 Creative Biolabs Business Overview
11.5.3 Creative Biolabs Antibody Discovery Services Product Features and Attributes
11.5.4 Creative Biolabs Antibody Discovery Services Revenue and Gross Margin (2020-2025)
11.5.5 Creative Biolabs Antibody Discovery Services Revenue by Product in 2024
11.5.6 Creative Biolabs Antibody Discovery Services Revenue by Application in 2024
11.5.7 Creative Biolabs Antibody Discovery Services Revenue by Geographic Area in 2024
11.5.8 Creative Biolabs Antibody Discovery Services SWOT Analysis
11.5.9 Creative Biolabs Recent Developments
11.6 Twist Bioscience
11.6.1 Twist Bioscience Corporation Information
11.6.2 Twist Bioscience Business Overview
11.6.3 Twist Bioscience Antibody Discovery Services Product Features and Attributes
11.6.4 Twist Bioscience Antibody Discovery Services Revenue and Gross Margin (2020-2025)
11.6.5 Twist Bioscience Recent Developments
11.7 Rapid Novor
11.7.1 Rapid Novor Corporation Information
11.7.2 Rapid Novor Business Overview
11.7.3 Rapid Novor Antibody Discovery Services Product Features and Attributes
11.7.4 Rapid Novor Antibody Discovery Services Revenue and Gross Margin (2020-2025)
11.7.5 Rapid Novor Recent Developments
11.8 Curia
11.8.1 Curia Corporation Information
11.8.2 Curia Business Overview
11.8.3 Curia Antibody Discovery Services Product Features and Attributes
11.8.4 Curia Antibody Discovery Services Revenue and Gross Margin (2020-2025)
11.8.5 Curia Recent Developments
11.9 AlivaMab Biologics
11.9.1 AlivaMab Biologics Corporation Information
11.9.2 AlivaMab Biologics Business Overview
11.9.3 AlivaMab Biologics Antibody Discovery Services Product Features and Attributes
11.9.4 AlivaMab Biologics Antibody Discovery Services Revenue and Gross Margin (2020-2025)
11.9.5 AlivaMab Biologics Recent Developments
11.10 Integrated DNA Technologies
11.10.1 Integrated DNA Technologies Corporation Information
11.10.2 Integrated DNA Technologies Business Overview
11.10.3 Integrated DNA Technologies Antibody Discovery Services Product Features and Attributes
11.10.4 Integrated DNA Technologies Antibody Discovery Services Revenue and Gross Margin (2020-2025)
11.10.5 Company Ten Recent Developments
11.11 Antibody Solutions
11.11.1 Antibody Solutions Corporation Information
11.11.2 Antibody Solutions Business Overview
11.11.3 Antibody Solutions Antibody Discovery Services Product Features and Attributes
11.11.4 Antibody Solutions Antibody Discovery Services Revenue and Gross Margin (2020-2025)
11.11.5 Antibody Solutions Recent Developments
11.12 Eurofins Discovery
11.12.1 Eurofins Discovery Corporation Information
11.12.2 Eurofins Discovery Business Overview
11.12.3 Eurofins Discovery Antibody Discovery Services Product Features and Attributes
11.12.4 Eurofins Discovery Antibody Discovery Services Revenue and Gross Margin (2020-2025)
11.12.5 Eurofins Discovery Recent Developments
11.13 GenScript
11.13.1 GenScript Corporation Information
11.13.2 GenScript Business Overview
11.13.3 GenScript Antibody Discovery Services Product Features and Attributes
11.13.4 GenScript Antibody Discovery Services Revenue and Gross Margin (2020-2025)
11.13.5 GenScript Recent Developments
11.14 Evotec
11.14.1 Evotec Corporation Information
11.14.2 Evotec Business Overview
11.14.3 Evotec Antibody Discovery Services Product Features and Attributes
11.14.4 Evotec Antibody Discovery Services Revenue and Gross Margin (2020-2025)
11.14.5 Evotec Recent Developments
11.15 Aurigene Pharmaceutical Services
11.15.1 Aurigene Pharmaceutical Services Corporation Information
11.15.2 Aurigene Pharmaceutical Services Business Overview
11.15.3 Aurigene Pharmaceutical Services Antibody Discovery Services Product Features and Attributes
11.15.4 Aurigene Pharmaceutical Services Antibody Discovery Services Revenue and Gross Margin (2020-2025)
11.15.5 Aurigene Pharmaceutical Services Recent Developments
11.16 Yumab
11.16.1 Yumab Corporation Information
11.16.2 Yumab Business Overview
11.16.3 Yumab Antibody Discovery Services Product Features and Attributes
11.16.4 Yumab Antibody Discovery Services Revenue and Gross Margin (2020-2025)
11.16.5 Yumab Recent Developments
11.17 Creative Bioarray
11.17.1 Creative Bioarray Corporation Information
11.17.2 Creative Bioarray Business Overview
11.17.3 Creative Bioarray Antibody Discovery Services Product Features and Attributes
11.17.4 Creative Bioarray Antibody Discovery Services Revenue and Gross Margin (2020-2025)
11.17.5 Creative Bioarray Recent Developments
11.18 CD ComputaBio
11.18.1 CD ComputaBio Corporation Information
11.18.2 CD ComputaBio Business Overview
11.18.3 CD ComputaBio Antibody Discovery Services Product Features and Attributes
11.18.4 CD ComputaBio Antibody Discovery Services Revenue and Gross Margin (2020-2025)
11.18.5 CD ComputaBio Recent Developments
11.19 Biomolecular Discovery Services
11.19.1 Biomolecular Discovery Services Corporation Information
11.19.2 Biomolecular Discovery Services Business Overview
11.19.3 Biomolecular Discovery Services Antibody Discovery Services Product Features and Attributes
11.19.4 Biomolecular Discovery Services Antibody Discovery Services Revenue and Gross Margin (2020-2025)
11.19.5 Biomolecular Discovery Services Recent Developments
11.20 ProteoGenix
11.20.1 ProteoGenix Corporation Information
11.20.2 ProteoGenix Business Overview
11.20.3 ProteoGenix Antibody Discovery Services Product Features and Attributes
11.20.4 ProteoGenix Antibody Discovery Services Revenue and Gross Margin (2020-2025)
11.20.5 ProteoGenix Recent Developments
11.21 Sichuan NB Biolab
11.21.1 Sichuan NB Biolab Corporation Information
11.21.2 Sichuan NB Biolab Business Overview
11.21.3 Sichuan NB Biolab Antibody Discovery Services Product Features and Attributes
11.21.4 Sichuan NB Biolab Antibody Discovery Services Revenue and Gross Margin (2020-2025)
11.21.5 Sichuan NB Biolab Recent Developments
11.22 Viva Biotech
11.22.1 Viva Biotech Corporation Information
11.22.2 Viva Biotech Business Overview
11.22.3 Viva Biotech Antibody Discovery Services Product Features and Attributes
11.22.4 Viva Biotech Antibody Discovery Services Revenue and Gross Margin (2020-2025)
11.22.5 Viva Biotech Recent Developments
11.23 SAFE Pharmaceutical Technology
11.23.1 SAFE Pharmaceutical Technology Corporation Information
11.23.2 SAFE Pharmaceutical Technology Business Overview
11.23.3 SAFE Pharmaceutical Technology Antibody Discovery Services Product Features and Attributes
11.23.4 SAFE Pharmaceutical Technology Antibody Discovery Services Revenue and Gross Margin (2020-2025)
11.23.5 SAFE Pharmaceutical Technology Recent Developments
11.24 Shanghai Medicilon
11.24.1 Shanghai Medicilon Corporation Information
11.24.2 Shanghai Medicilon Business Overview
11.24.3 Shanghai Medicilon Antibody Discovery Services Product Features and Attributes
11.24.4 Shanghai Medicilon Antibody Discovery Services Revenue and Gross Margin (2020-2025)
11.24.5 Shanghai Medicilon Recent Developments
11.25 WuXi Biologics
11.25.1 WuXi Biologics Corporation Information
11.25.2 WuXi Biologics Business Overview
11.25.3 WuXi Biologics Antibody Discovery Services Product Features and Attributes
11.25.4 WuXi Biologics Antibody Discovery Services Revenue and Gross Margin (2020-2025)
11.25.5 WuXi Biologics Recent Developments
11.26 XtalPi
11.26.1 XtalPi Corporation Information
11.26.2 XtalPi Business Overview
11.26.3 XtalPi Antibody Discovery Services Product Features and Attributes
11.26.4 XtalPi Antibody Discovery Services Revenue and Gross Margin (2020-2025)
11.26.5 XtalPi Recent Developments
11.27 Detaibio
11.27.1 Detaibio Corporation Information
11.27.2 Detaibio Business Overview
11.27.3 Detaibio Antibody Discovery Services Product Features and Attributes
11.27.4 Detaibio Antibody Discovery Services Revenue and Gross Margin (2020-2025)
11.27.5 Detaibio Recent Developments
11.28 Cusabio
11.28.1 Cusabio Corporation Information
11.28.2 Cusabio Business Overview
11.28.3 Cusabio Antibody Discovery Services Product Features and Attributes
11.28.4 Cusabio Antibody Discovery Services Revenue and Gross Margin (2020-2025)
11.28.5 Cusabio Recent Developments
12 Antibody Discovery ServicesIndustry Chain Analysis
12.1 Antibody Discovery Services Industry Chain
12.2 Upstream Analysis
12.2.1 Upstream Key Suppliers
12.3 Middlestream Analysis
12.4 Downstream Sales Model and Distribution Networks
12.4.1 Sales Channels
12.4.2 Distributors
13 Antibody Discovery Services Market Dynamics
13.1 Industry Trends and Evolution
13.2 Market Growth Drivers and Emerging Opportunities
13.3 Market Challenges, Risks, and Restraints
14 Key Findings in the Global Antibody Discovery Services Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details

List of Tables
Table 1. Global Antibody Discovery Services Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Table 2. Global Antibody Discovery Services Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Table 3. Global Antibody Discovery Services Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 4. Global Antibody Discovery Services Revenue by Region (2020-2025) & (US$ Million)
Table 5. Global Antibody Discovery Services Revenue by Region (2026-2031) & (US$ Million)
Table 6. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 7. Global Antibody Discovery Services Revenue by Players (2020-2025) & (US$ Million)
Table 8. Global Antibody Discovery Services Revenue Market Share by Players (2020-2025)
Table 9. Global Key Players’Ranking Shift (2023 vs. 2024) (Based on Revenue)
Table 10. Global Antibody Discovery Services by Player Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Antibody Discovery Services as of 2024)
Table 11. Global Antibody Discovery Services Average Gross Margin (%) by Player (2020 VS 2024)
Table 12. Global Antibody Discovery Services Companies Headquarters
Table 13. Global Antibody Discovery Services Market Concentration Ratio (CR5 and HHI)
Table 14. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
Table 15. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
Table 16. Global Antibody Discovery Services Revenue by Type (2020-2025) & (US$ Million)
Table 17. Global Antibody Discovery Services Revenue by Type (2026-2031) & (US$ Million)
Table 18. Key Product Attributes and Differentiation
Table 19. Global Antibody Discovery Services Revenue by Application (2020-2025) & (US$ Million)
Table 20. Global Antibody Discovery Services Revenue by Application (2026-2031) & (US$ Million)
Table 21. Antibody Discovery Services High-Growth Sectors Demand CAGR (2024-2031)
Table 22. Top Customers by Region
Table 23. Top Customers by Application
Table 24. North America Antibody Discovery Services Growth Accelerators and Market Barriers
Table 25. North America Antibody Discovery Services Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 26. Europe Antibody Discovery Services Growth Accelerators and Market Barriers
Table 27. Europe Antibody Discovery Services Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 28. Asia-Pacific Antibody Discovery Services Growth Accelerators and Market Barriers
Table 29. Asia-Pacific Antibody Discovery Services Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 30. Central and South America Antibody Discovery Services Investment Opportunities and Key Challenges
Table 31. Central and South America Antibody Discovery Services Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 32. Middle East and Africa Antibody Discovery Services Investment Opportunities and Key Challenges
Table 33. Middle East and Africa Antibody Discovery Services Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 34. Biocytogen Corporation Information
Table 35. Biocytogen Description and Major Businesses
Table 36. Biocytogen Product Features and Attributes
Table 37. Biocytogen Revenue (US$ Million) and Gross Margin (2020-2025)
Table 38. Biocytogen Revenue Proportion by Product in 2024
Table 39. Biocytogen Revenue Proportion by Application in 2024
Table 40. Biocytogen Revenue Proportion by Geographic Area in 2024
Table 41. Biocytogen Antibody Discovery Services SWOT Analysis
Table 42. Biocytogen Recent Developments
Table 43. Charles River Laboratories Corporation Information
Table 44. Charles River Laboratories Description and Major Businesses
Table 45. Charles River Laboratories Product Features and Attributes
Table 46. Charles River Laboratories Revenue (US$ Million) and Gross Margin (2020-2025)
Table 47. Charles River Laboratories Revenue Proportion by Product in 2024
Table 48. Charles River Laboratories Revenue Proportion by Application in 2024
Table 49. Charles River Laboratories Revenue Proportion by Geographic Area in 2024
Table 50. Charles River Laboratories Antibody Discovery Services SWOT Analysis
Table 51. Charles River Laboratories Recent Developments
Table 52. Abcam Corporation Information
Table 53. Abcam Description and Major Businesses
Table 54. Abcam Product Features and Attributes
Table 55. Abcam Revenue (US$ Million) and Gross Margin (2020-2025)
Table 56. Abcam Revenue Proportion by Product in 2024
Table 57. Abcam Revenue Proportion by Application in 2024
Table 58. Abcam Revenue Proportion by Geographic Area in 2024
Table 59. Abcam Antibody Discovery Services SWOT Analysis
Table 60. Abcam Recent Developments
Table 61. Alloy Therapeutics Corporation Information
Table 62. Alloy Therapeutics Description and Major Businesses
Table 63. Alloy Therapeutics Product Features and Attributes
Table 64. Alloy Therapeutics Revenue (US$ Million) and Gross Margin (2020-2025)
Table 65. Alloy Therapeutics Revenue Proportion by Product in 2024
Table 66. Alloy Therapeutics Revenue Proportion by Application in 2024
Table 67. Alloy Therapeutics Revenue Proportion by Geographic Area in 2024
Table 68. Alloy Therapeutics Antibody Discovery Services SWOT Analysis
Table 69. Alloy Therapeutics Recent Developments
Table 70. Creative Biolabs Corporation Information
Table 71. Creative Biolabs Description and Major Businesses
Table 72. Creative Biolabs Product Features and Attributes
Table 73. Creative Biolabs Revenue (US$ Million) and Gross Margin (2020-2025)
Table 74. Creative Biolabs Revenue Proportion by Product in 2024
Table 75. Creative Biolabs Revenue Proportion by Application in 2024
Table 76. Creative Biolabs Revenue Proportion by Geographic Area in 2024
Table 77. Creative Biolabs Antibody Discovery Services SWOT Analysis
Table 78. Creative Biolabs Recent Developments
Table 79. Twist Bioscience Corporation Information
Table 80. Twist Bioscience Description and Major Businesses
Table 81. Twist Bioscience Product Features and Attributes
Table 82. Twist Bioscience Revenue (US$ Million) and Gross Margin (2020-2025)
Table 83. Twist Bioscience Recent Developments
Table 84. Rapid Novor Corporation Information
Table 85. Rapid Novor Description and Major Businesses
Table 86. Rapid Novor Product Features and Attributes
Table 87. Rapid Novor Revenue (US$ Million) and Gross Margin (2020-2025)
Table 88. Rapid Novor Recent Developments
Table 89. Curia Corporation Information
Table 90. Curia Description and Major Businesses
Table 91. Curia Product Features and Attributes
Table 92. Curia Revenue (US$ Million) and Gross Margin (2020-2025)
Table 93. Curia Recent Developments
Table 94. AlivaMab Biologics Corporation Information
Table 95. AlivaMab Biologics Description and Major Businesses
Table 96. AlivaMab Biologics Product Features and Attributes
Table 97. AlivaMab Biologics Revenue (US$ Million) and Gross Margin (2020-2025)
Table 98. AlivaMab Biologics Recent Developments
Table 99. Integrated DNA Technologies Corporation Information
Table 100. Integrated DNA Technologies Description and Major Businesses
Table 101. Integrated DNA Technologies Product Features and Attributes
Table 102. Integrated DNA Technologies Revenue (US$ Million) and Gross Margin (2020-2025)
Table 103. Integrated DNA Technologies Recent Developments
Table 104. Antibody Solutions Corporation Information
Table 105. Antibody Solutions Description and Major Businesses
Table 106. Antibody Solutions Product Features and Attributes
Table 107. Antibody Solutions Revenue (US$ Million) and Gross Margin (2020-2025)
Table 108. Antibody Solutions Recent Developments
Table 109. Eurofins Discovery Corporation Information
Table 110. Eurofins Discovery Description and Major Businesses
Table 111. Eurofins Discovery Product Features and Attributes
Table 112. Eurofins Discovery Revenue (US$ Million) and Gross Margin (2020-2025)
Table 113. Eurofins Discovery Recent Developments
Table 114. GenScript Corporation Information
Table 115. GenScript Description and Major Businesses
Table 116. GenScript Product Features and Attributes
Table 117. GenScript Revenue (US$ Million) and Gross Margin (2020-2025)
Table 118. GenScript Recent Developments
Table 119. Evotec Corporation Information
Table 120. Evotec Description and Major Businesses
Table 121. Evotec Product Features and Attributes
Table 122. Evotec Revenue (US$ Million) and Gross Margin (2020-2025)
Table 123. Evotec Recent Developments
Table 124. Aurigene Pharmaceutical Services Corporation Information
Table 125. Aurigene Pharmaceutical Services Description and Major Businesses
Table 126. Aurigene Pharmaceutical Services Product Features and Attributes
Table 127. Aurigene Pharmaceutical Services Revenue (US$ Million) and Gross Margin (2020-2025)
Table 128. Aurigene Pharmaceutical Services Recent Developments
Table 129. Yumab Corporation Information
Table 130. Yumab Description and Major Businesses
Table 131. Yumab Product Features and Attributes
Table 132. Yumab Revenue (US$ Million) and Gross Margin (2020-2025)
Table 133. Yumab Recent Developments
Table 134. Creative Bioarray Corporation Information
Table 135. Creative Bioarray Description and Major Businesses
Table 136. Creative Bioarray Product Features and Attributes
Table 137. Creative Bioarray Revenue (US$ Million) and Gross Margin (2020-2025)
Table 138. Creative Bioarray Recent Developments
Table 139. CD ComputaBio Corporation Information
Table 140. CD ComputaBio Description and Major Businesses
Table 141. CD ComputaBio Product Features and Attributes
Table 142. CD ComputaBio Revenue (US$ Million) and Gross Margin (2020-2025)
Table 143. CD ComputaBio Recent Developments
Table 144. Biomolecular Discovery Services Corporation Information
Table 145. Biomolecular Discovery Services Description and Major Businesses
Table 146. Biomolecular Discovery Services Product Features and Attributes
Table 147. Biomolecular Discovery Services Revenue (US$ Million) and Gross Margin (2020-2025)
Table 148. Biomolecular Discovery Services Recent Developments
Table 149. ProteoGenix Corporation Information
Table 150. ProteoGenix Description and Major Businesses
Table 151. ProteoGenix Product Features and Attributes
Table 152. ProteoGenix Revenue (US$ Million) and Gross Margin (2020-2025)
Table 153. ProteoGenix Recent Developments
Table 154. Sichuan NB Biolab Corporation Information
Table 155. Sichuan NB Biolab Description and Major Businesses
Table 156. Sichuan NB Biolab Product Features and Attributes
Table 157. Sichuan NB Biolab Revenue (US$ Million) and Gross Margin (2020-2025)
Table 158. Sichuan NB Biolab Recent Developments
Table 159. Viva Biotech Corporation Information
Table 160. Viva Biotech Description and Major Businesses
Table 161. Viva Biotech Product Features and Attributes
Table 162. Viva Biotech Revenue (US$ Million) and Gross Margin (2020-2025)
Table 163. Viva Biotech Recent Developments
Table 164. SAFE Pharmaceutical Technology Corporation Information
Table 165. SAFE Pharmaceutical Technology Description and Major Businesses
Table 166. SAFE Pharmaceutical Technology Product Features and Attributes
Table 167. SAFE Pharmaceutical Technology Revenue (US$ Million) and Gross Margin (2020-2025)
Table 168. SAFE Pharmaceutical Technology Recent Developments
Table 169. Shanghai Medicilon Corporation Information
Table 170. Shanghai Medicilon Description and Major Businesses
Table 171. Shanghai Medicilon Product Features and Attributes
Table 172. Shanghai Medicilon Revenue (US$ Million) and Gross Margin (2020-2025)
Table 173. Shanghai Medicilon Recent Developments
Table 174. WuXi Biologics Corporation Information
Table 175. WuXi Biologics Description and Major Businesses
Table 176. WuXi Biologics Product Features and Attributes
Table 177. WuXi Biologics Revenue (US$ Million) and Gross Margin (2020-2025)
Table 178. WuXi Biologics Recent Developments
Table 179. XtalPi Corporation Information
Table 180. XtalPi Description and Major Businesses
Table 181. XtalPi Product Features and Attributes
Table 182. XtalPi Revenue (US$ Million) and Gross Margin (2020-2025)
Table 183. XtalPi Recent Developments
Table 184. Detaibio Corporation Information
Table 185. Detaibio Description and Major Businesses
Table 186. Detaibio Product Features and Attributes
Table 187. Detaibio Revenue (US$ Million) and Gross Margin (2020-2025)
Table 188. Detaibio Recent Developments
Table 189. Cusabio Corporation Information
Table 190. Cusabio Description and Major Businesses
Table 191. Cusabio Product Features and Attributes
Table 192. Cusabio Revenue (US$ Million) and Gross Margin (2020-2025)
Table 193. Cusabio Recent Developments
Table 194. Raw Materials Key Suppliers
Table 195. Distributors List
Table 196. Market Trends and Market Evolution
Table 197. Market Drivers and Opportunities
Table 198. Market Challenges, Risks, and Restraints
Table 199. Research Programs/Design for This Report
Table 200. Key Data Information from Secondary Sources
Table 201. Key Data Information from Primary Sources


List of Figures
Figure 1. Antibody Discovery Services Product Picture
Figure 2. Global Antibody Discovery Services Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Figure 3. Discovery of CAR-T Antibody Drugs Product Picture
Figure 4. Discovery of Monoclonal Antibody Drugs Product Picture
Figure 5. Discovery of ADC Antibody Drugs Product Picture
Figure 6. Others Product Picture
Figure 7. Global Antibody Discovery Services Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Figure 8. Biotechnology
Figure 9. Medical
Figure 10. University
Figure 11. Others
Figure 12. Antibody Discovery Services Report Years Considered
Figure 13. Global Antibody Discovery Services Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 14. Global Antibody Discovery Services Revenue (2020-2031) & (US$ Million)
Figure 15. Global Antibody Discovery Services Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Figure 16. Global Antibody Discovery Services Revenue Market Share by Region (2020-2031)
Figure 17. Global Antibody Discovery Services Revenue Market Share Ranking (2024)
Figure 18. Tier Distribution by Revenue Contribution (2020 VS 2024)
Figure 19. Discovery of CAR-T Antibody Drugs Revenue Market Share by Player in 2024
Figure 20. Discovery of Monoclonal Antibody Drugs Revenue Market Share by Player in 2024
Figure 21. Discovery of ADC Antibody Drugs Revenue Market Share by Player in 2024
Figure 22. Others Revenue Market Share by Player in 2024
Figure 23. Global Antibody Discovery Services Revenue Market Share by Type (2020-2031)
Figure 24. Global Antibody Discovery Services Revenue Market Share by Application (2020-2031)
Figure 25. North America Antibody Discovery Services Revenue YoY (2020-2031) & (US$ Million)
Figure 26. North America Top 5 Players Antibody Discovery Services Revenue (US$ Million) in 2024
Figure 27. North America Antibody Discovery Services Revenue (US$ Million) by Type (2020 - 2031)
Figure 28. North America Antibody Discovery Services Revenue (US$ Million) by Application (2020-2031)
Figure 29. US Antibody Discovery Services Revenue (2020-2031) & (US$ Million)
Figure 30. Canada Antibody Discovery Services Revenue (2020-2031) & (US$ Million)
Figure 31. Mexico Antibody Discovery Services Revenue (2020-2031) & (US$ Million)
Figure 32. Europe Antibody Discovery Services Revenue YoY (2020-2031) & (US$ Million)
Figure 33. Europe Top 5 Players Antibody Discovery Services Revenue (US$ Million) in 2024
Figure 34. Europe Antibody Discovery Services Revenue (US$ Million) by Type (2020-2031)
Figure 35. Europe Antibody Discovery Services Revenue (US$ Million) by Application (2020-2031)
Figure 36. Germany Antibody Discovery Services Revenue (2020-2031) & (US$ Million)
Figure 37. France Antibody Discovery Services Revenue (2020-2031) & (US$ Million)
Figure 38. U.K. Antibody Discovery Services Revenue (2020-2031) & (US$ Million)
Figure 39. Italy Antibody Discovery Services Revenue (2020-2031) & (US$ Million)
Figure 40. Russia Antibody Discovery Services Revenue (2020-2031) & (US$ Million)
Figure 41. Asia-Pacific Antibody Discovery Services Revenue YoY (2020-2031) & (US$ Million)
Figure 42. Asia-Pacific Top 8 Players Antibody Discovery Services Revenue (US$ Million) in 2024
Figure 43. Asia-Pacific Antibody Discovery Services Revenue (US$ Million) by Type (2020-2031)
Figure 44. Asia-Pacific Antibody Discovery Services Revenue (US$ Million) by Application (2020-2031)
Figure 45. Indonesia Antibody Discovery Services Revenue (2020-2031) & (US$ Million)
Figure 46. Japan Antibody Discovery Services Revenue (2020-2031) & (US$ Million)
Figure 47. South Korea Antibody Discovery Services Revenue (2020-2031) & (US$ Million)
Figure 48. Australia Antibody Discovery Services Revenue (2020-2031) & (US$ Million)
Figure 49. India Antibody Discovery Services Revenue (2020-2031) & (US$ Million)
Figure 50. Indonesia Antibody Discovery Services Revenue (2020-2031) & (US$ Million)
Figure 51. Vietnam Antibody Discovery Services Revenue (2020-2031) & (US$ Million)
Figure 52. Malaysia Antibody Discovery Services Revenue (2020-2031) & (US$ Million)
Figure 53. Philippines Antibody Discovery Services Revenue (2020-2031) & (US$ Million)
Figure 54. Singapore Antibody Discovery Services Revenue (2020-2031) & (US$ Million)
Figure 55. Central and South America Antibody Discovery Services Revenue YoY (2020-2031) & (US$ Million)
Figure 56. Central and South America Top 5 Players Antibody Discovery Services Revenue (US$ Million) in 2024
Figure 57. Central and South America Antibody Discovery Services Revenue (US$ Million) by Type (2020-2031)
Figure 58. Central and South America Antibody Discovery Services Revenue (US$ Million) by Application (2020-2031)
Figure 59. Brazil Antibody Discovery Services Revenue (2020-2025) & (US$ Million)
Figure 60. Argentina Antibody Discovery Services Revenue (2020-2025) & (US$ Million)
Figure 61. Middle East and Africa Antibody Discovery Services Revenue YoY (2020-2031) & (US$ Million)
Figure 62. Middle East and Africa Top 5 Players Antibody Discovery Services Revenue (US$ Million) in 2024
Figure 63. South America Antibody Discovery Services Revenue (US$ Million) by Type (2020-2031)
Figure 64. Middle East and Africa Antibody Discovery Services Revenue (US$ Million) by Application (2020-2031)
Figure 65. GCC Countries Antibody Discovery Services Revenue (2020-2025) & (US$ Million)
Figure 66. Israel Antibody Discovery Services Revenue (2020-2025) & (US$ Million)
Figure 67. Egypt Antibody Discovery Services Revenue (2020-2025) & (US$ Million)
Figure 68. South Africa Antibody Discovery Services Revenue (2020-2025) & (US$ Million)
Figure 69. Antibody Discovery Services Industry Chain Mapping
Figure 70. Channels of Distribution (Direct Vs Distribution)
Figure 71. Bottom-up and Top-down Approaches for This Report
Figure 72. Data Triangulation
Figure 73. Key Executives Interviewed

Your Name

Your E-mail

Your message

Submit